0001609351-18-000028.txt : 20180416
0001609351-18-000028.hdr.sgml : 20180416
20180416174903
ACCESSION NUMBER: 0001609351-18-000028
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171012
FILED AS OF DATE: 20180416
DATE AS OF CHANGE: 20180416
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SIGAL ELLIOT
CENTRAL INDEX KEY: 0001202294
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36819
FILM NUMBER: 18757509
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spark Therapeutics, Inc.
CENTRAL INDEX KEY: 0001609351
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462654405
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: 888-772-7560
MAIL ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
4
1
wf-form4_152391529825009.xml
FORM 4
X0306
4
2017-10-12
0
0001609351
Spark Therapeutics, Inc.
ONCE
0001202294
SIGAL ELLIOT
C/O SPARK THERAPEUTICS, INC.
3737 MARKET STREET, SUITE 1300
PHILADELPHIA
PA
19104
1
0
0
0
Common Stock
2017-10-12
4
P
0
29
90.75
A
11243
D
Common Stock
2017-11-28
4
S
0
29
72.43
D
11214
D
Reflects transactions occurring in a brokerage account managed by an investment advisor who maintained discretionary authority over the account. The transactions were made by the investment advisor in contradiction of the Reporting Person's instructions and without the Reporting Person's approval.
/s/ Joseph W. La Barge Attorney-in-Fact for Elliott Sigal
2018-04-16